References
- Gent M, Blakely J A, Easton J D. The Canadian American Ticlopidine Study (CATS) in thromboembolic strok. Lancet 1989; 1: 1215–1220
- Hass W K, Easton J D, Adams HP, Jr, Pryse-Phillips W, Molony B A, Anderson S, Kamm B. A randomized trial comparing toclopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989; 321: 501–507
- Deschamps J P, Lassegue A, Ottignon Y, Vuitton D, Allemand H, Carayon P, Miguet JP. Cholestatic jaundice associated with ingestion of ticlopidine: apropos of the first two cases. Gastroenterol Clin Biol 1982; 6: 595–596
- Eugene C, Lefebre J F, Gury B, Quevauvilliers J. Cholestatic hepatitis. Prisumptive role of ticlopidine. Sem Hop 1983; 59: 2923–2924
- Biour M, Toussaint P, Duhamel G, Canuel C, Krulick M, Calmus Y. Ticlopidine: blood and liver involvement. Therapie 1982; 37: 222–224
- Mammarella A, Paoletti V, Moroni C, Cassone R. Ticlopidine-induced cholestatic jaundice. Clin Ther 1991; 138: 45–46
- Miyahara K, Kasahara N, Kondo Y, Imai Y, Matuzaki F. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Jpn J Med 1991; 30: 354–359
- Biour M, Poupon R, Grange J D, Chazouilleres O, Levy V G, Bodin F, Cheymol G. Hepatotoxicity of drugs. An updated bibliographic database of liver diseases and related drugs. Gastroenterol Clin Biol 1992; 16: 64–88
- Sondag D, Bader R, Claude P, Schreiber M. Hepatitis due to ticlopidine: a new case. Ann Gastroenterol Hepatol 1993; 29: 40–41
- Greany J J, Jr, Hess D A, Mahoney CD. Ticlopidine-induced cholestatic jaundice. Clin Pharm 1993; 12: 398–399
- Nurhussein MA. Ticlopidine-induced prolonged cholestasis. J Am Geriatr Soc 1993; 41: 1371–1372
- Grimm I S, Litynski JJ. Severe cholestasis associated with ticlopidine. Am J Gastroenterol 1994; 89: 279–280